Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Just a thought--

Could be any number of players that are buying up the stock.

Is the value of the number of shares outstanding a cheap bargain price to pay for control of the MMP? I mean some shares are already in strong hands. But if someone (or a group) controls half the shares (plus one) they still would then have controling interest.

Share
New Message
Please login to post a reply